IgM and stromal cell-associated heparan sulfate/heparin as complement-independent ligands for CD19

European Journal of Immunology

Volumn 31, Issue 7, 2001, Pages 2189-2199

  De Fougerolles, Antonin R ^a   Batista, Facundo ^a   Johnsson, Eskil ^a   Fearon, Douglas T ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

B cell; CD19; Heparan sulfate; Heparin; IgM

Indexed keywords

CD19 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; HEPARAN SULFATE; HEPARIN; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL LINE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DENDRITIC CELL; EMBRYO; GERMINAL CENTER; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; RESIDUE ANALYSIS; STROMA CELL;

ANIMALS; ANTIGENS, CD19; CELL LINE; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; DENDRITIC CELLS; GERMINAL CENTER; HEPARIN; HEPARITIN SULFATE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIGANDS; MICE; MICE, INBRED BALB C; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; STROMAL CELLS;

EID: 0034934083     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200107)31:7<2189::AID-IMMU2189>3.0.CO;2-V     Document Type: Article

References (49)

1. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex
2. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig
3. Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade
4. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin
5. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes
6. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes
7. Regulation of B lymphocyte development and activation by the CD19/ CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19
8. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains
9. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase
10. The signaling activity of murine CD19 is regulated during cell development
11. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors
12. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling
13. CD19 as a membrane-anchored adaptor protein of B lymphocytes: Costimulation of lipid and protein kinases by recruitment of Vav
14. 2+ mobilization is integrated by CD19 dephosphorylation
15. Co-ligation of the antigen and Fc receptors gives rise to the selective modulation of intracellular signaling in B cells. Regulation of the association of phosphatidylinositol 3-kinase and inositol 5'-phosphatase with the antigen
16. Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation
17. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice
18. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
19. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes
20. Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex
21. Inersection of the complement and immune systems: A signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19
22. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
23. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen
24. Antibody response to a T-dependent antigen requires B cell expression of complement receptors
25. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
26. Self-renewal of B-1 lymphocytes is dependent on CD19
27. Germ-free mice reared on an "antigen-free" diet
28. Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/mice fed chemically defined ultrafiltered diet
29. Structure and domain organization of the CD19 antigen of human, mouse, and guinea pig B lymphocytes. Conservation of the extensive cytoplasmic domain
30. The origin of follicular dendritic cells in the mouse and the mechanism of trapping of immune complexes on them
31. Follicular dendritic cells in germinal centre development
32. Host origin of follicular dendritic cells induced in the spleen of SCID mice after transfer of allogeneic lymphocytes
33. Follicular dendritic cell (FDC) precursors in primary lymphoid tissues
34. Lymphoproliferative disorders in IL-7 transgenic mice: Expansion of immature B cells which retain macrophage potential
35. Isolation of follicular dendritic cells from human tonsils and adenoids. II. Immunocytochemical characterization
36. Follicular dendritic cell-dependent adhesion and proliferation of B cells in vitro
37. Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19
38. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response
39. The signaling activity of murine CD19 is regulated during cell development
40. Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors
41. The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13
42. Normal lymphocyte development but delayed humoral immune response in CD81-null mice
43. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice
44. + cells in newborn liver
45. A new adipose cell line derived from newborn mouse calvaria can promote the proliferation of pluripotent stem cells in vitro
46. Stromal cell lines which support lymphocyte growth: Characterization, sensitivity to radiation and responsiveness to growth factors
47. A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis
48. Cloning cell surface molecules by transient expression in mammalian cells
49. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily